Artivion (AORT) Return on Capital Employed (2011 - 2026)
Artivion (AORT) reported Return on Capital Employed of 4.72% for Q1 2026, up 260.0% on a YoY basis from 1.31% in Q1 2025, and up 7.77% quarter-over-quarter from 4.38% in Q4 2025.
Artivion (AORT) Return on Capital Employed (2011 - 2026) Analysis & Trends
Artivion has reported Return on Capital Employed for 16 years, with the latest figure at 4.72% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 260.0% year-over-year to 4.72%; the trailing twelve-month figure through Mar 2026 stood at 4.72% (up 260.0% YoY), and the FY2025 full-year result was 4.59%, down 78.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 4.72%, up from 4.38% in the prior quarter.
- The five-year high for Return on Capital Employed was 6.12% in Q3 2024, with the low at 1.03% in Q3 2022.
- Historically, Return on Capital Employed has averaged 2.51% across 5 years, with a median of 2.13% in 2025.
- Annual changes were most pronounced in 2022 — Return on Capital Employed slumped 360 bps — and 2024, when it soared 519 bps.
- Artivion's Return on Capital Employed stood at 0.88% in 2022, then decreased by 10 bps to 0.79% in 2023, then surged by 574 bps to 5.33% in 2024, then slipped by 18 bps to 4.38% in 2025, then advanced by 8 bps to 4.72% in 2026.
- The last three Return on Capital Employed figures came in at 4.72% (Q1 2026), 4.38% (Q4 2025), and 3.38% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Artivion | 1.02 Bn | 961.48 Mn | 75.45 Mn | 4.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.72% |
| Dec 31, 2025 | 4.38% |
| Sep 30, 2025 | 3.38% |
| Jun 30, 2025 | 2.35% |
| Mar 31, 2025 | 2.13% |
| Dec 31, 2024 | 5.33% |
| Sep 30, 2024 | 6.12% |
| Jun 30, 2024 | 4.58% |
| Mar 31, 2024 | 4.70% |
| Dec 31, 2023 | 0.79% |
| Sep 30, 2023 | 0.93% |
| Jun 30, 2023 | 0.54% |
| Mar 31, 2023 | 0.10% |
| Dec 31, 2022 | 0.88% |
| Sep 30, 2022 | -1.03% |
| Jun 30, 2022 | 1.58% |
| Mar 31, 2022 | 1.12% |
| Dec 31, 2021 | 1.07% |
| Sep 30, 2021 | 2.57% |
| Jun 30, 2021 | 1.12% |